| Trial ID: | L1188 |
| Source ID: | NCT01271478
|
| Associated Drug: |
Captopril Plus Placebo
|
| Title: |
Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Inflammation|End-stage Renal Disease
|
| Interventions: |
DRUG: captopril plus placebo|DRUG: telmisartan plus placebo|DRUG: Telmisartan plus Captopril|DRUG: Placebo
|
| Outcome Measures: |
Primary: Serum concentrations of TNF-a, IL-6 and CRP, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Coordinación de Investigación en Salud, Mexico
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-08
|
| Completion Date: |
2013-08-31
|
| Results First Posted: |
|
| Last Update Posted: |
2018-12-19
|
| Locations: |
Hospital de Especialidades, CMNO, IMSS, Guadalajara, Jalisco, 44320, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01271478
|
